크레젯정10/5밀리그램(에제티미브|로수바스타틴)
Recall Summary Cresjet 10/5mg tablets (containing ezetimibe and rosuvastatin) are being recalled because the packaging label lists an incorrect number of tablets inside the box. This recall affects specific batches distributed in South Korea and is classified as a Class II recall by the manufacturer Daewoong Pharmaceutical.
- Recalling firm
- (주)대웅제약
- Product
- 크레젯정10/5밀리그램(에제티미브|로수바스타틴) (Barcode: 8806416061503, 8806416061510, 8806416061527, 8806416061534)
- Reason
- 포장단위표시사항불일치(정제수량오기)에따른영업자회수
- Classification
- Class II
- Category
- drug recall
- Country
- South Korea
- Agency
- MFDS-DRUG
- Recall date
- 2026-07-07
- Status
- Ongoing
- Distribution
- South Korea
Official recall notice from MFDS-DRUG
Recall details on Nibble Recalls: https://trynibble.app/recalls/4f1a1b82-66db-44a7-8629-dda6b9c63c7a